Bio-Techne (TECH) Capital Expenditures Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 227.76% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.57% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 143.40% |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn | -10.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.24% |
| Dec 31, 2025 | -13.19% |
| Sep 30, 2025 | -41.53% |
| Jun 30, 2025 | -72.80% |
| Mar 31, 2025 | -38.43% |
| Dec 31, 2024 | -54.11% |
| Sep 30, 2024 | -32.52% |
| Jun 30, 2024 | 66.00% |
| Mar 31, 2024 | 39.95% |
| Dec 31, 2023 | 143.31% |
| Sep 30, 2023 | 42.24% |
| Jun 30, 2023 | -20.18% |
| Mar 31, 2023 | -22.20% |
| Dec 31, 2022 | -39.92% |
| Sep 30, 2022 | 57.43% |
| Jun 30, 2022 | 19.92% |
| Mar 31, 2022 | 42.43% |
| Dec 31, 2021 | -11.16% |
| Sep 30, 2021 | -44.51% |
| Jun 30, 2021 | -34.86% |
| Mar 31, 2021 | 14.22% |
| Dec 31, 2020 | -21.42% |
| Sep 30, 2020 | 3.92% |
| Jun 30, 2020 | 48.59% |
| Mar 31, 2020 | 88.47% |
| Dec 31, 2019 | 216.33% |
| Sep 30, 2019 | 151.19% |
| Jun 30, 2019 | 100.96% |
| Mar 31, 2019 | 40.39% |
| Dec 31, 2018 | -27.32% |
| Sep 30, 2018 | -20.54% |
| Jun 30, 2018 | -0.85% |
| Mar 31, 2018 | -12.65% |
| Dec 31, 2017 | 122.05% |
| Sep 30, 2017 | 115.93% |
| Jun 30, 2017 | 92.14% |
| Mar 31, 2017 | 41.61% |
| Dec 31, 2016 | -41.62% |
| Sep 30, 2016 | -60.10% |
| Jun 30, 2016 | -55.96% |
| Mar 31, 2016 | -42.40% |
| Dec 31, 2015 | 55.54% |
| Sep 30, 2015 | 24.79% |
| Jun 30, 2015 | 229.88% |
| Mar 31, 2015 | 15.56% |
| Dec 31, 2014 | -13.85% |
| Sep 30, 2014 | 28.71% |
| Jun 30, 2014 | -60.68% |
| Mar 31, 2014 | -33.14% |
| Dec 31, 2013 | -55.63% |
| Sep 30, 2013 | 51.53% |
| Jun 30, 2013 | 371.84% |
| Mar 31, 2013 | 301.58% |
| Dec 31, 2012 | 273.47% |
| Sep 30, 2012 | 129.47% |
| Jun 30, 2012 | -11.00% |
| Mar 31, 2012 | 168.07% |
| Dec 31, 2011 | 208.70% |
| Sep 30, 2011 | 4.18% |
| Jun 30, 2011 | 13.36% |
| Mar 31, 2011 | -56.66% |
| Dec 31, 2010 | -55.21% |
| Sep 30, 2010 | 86.86% |